HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PPP Loans Landed By Nearly 25% Of Natural Product Firms That Tried Again – NPA

Executive Summary

Natural products companies fared better in the second round of CARES Act federal PPP funding as a Natural Products Association survey showed 25% that re-applied were successful. It also found 70% of businesses surveyed applied for assistance in the second tranche, which has $120bn still available.

You may also be interested in...



Natural Products Sector Will Try Again With $310Bn More Available For Small Business PPP Loans

NPA found 95% percent of natural food, supplement and cosmetic marketers that applied for a small business loan under CARES Act funding were denied. But industry is hopeful $310bn more made available will lead to more successful applications.

GSK Enters Race For OTC COVID-19 Test With Mammoth Biosciences As Partner

GSK partners with biotech firm Mammoth Biosciences to develop a home-use OTC nasal swab test for COVID-19 that works in less than 20 minutes. Mammoth says the firms will seek an FDA emergency use authorization for the test, roll it out first to clinics and will seek approval for OTC sales. 

Zing Patch, Nubrain Water, Stay Alert Gummy: Alternatives To Caffeine In Energy Booster Space

Thync Global’s Zing Energy neurostimulation patch and Tesla Nootropics’ Nubrain Brainstorm caffeine-free water are promoted as alternatives to caffeine and energy drinks. They join a market dominated by big brands but with competition growing from products that boost energy without caffeine and sugar.

Topics

UsernamePublicRestriction

Register

SC142283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel